期刊文献+

循环小分子RNA:消化道肿瘤的分子传感器

Molecular Microsensors in The Digestive Tract Cancer: Circulating Micro RNAs
原文传递
导出
摘要 目的总结循环小分子RNA(mi RNAs)与消化道肿瘤的关系,以及其在消化道肿瘤诊断、治疗及预后判断中的应用前景。方法收集国内外关于mi RNAs与消化道肿瘤关系的文献并作综述。结果 mi RNAs可通过基因调控作用,参与调节细胞的增殖、分化和凋亡。消化道肿瘤患者的血循环中常伴有一些异常表达的mi RNAs,其与肿瘤的发生和发展密切相关,不仅有助于肿瘤的诊断,而且还有助于确定肿瘤原发灶部位,甚至有助于临床和病理分期,由此预测肿瘤的进展、复发和转移情况,评估治疗效果等。结论循环mi RNAs可作为消化道肿瘤的分子传感器,用于临床消化道肿瘤的无创早期诊断、治疗和预后评估。 Objective To summarize the relationship between micro RNAs(mi RNAs) and the digestive tract cancer, and to investigate the applicative value of mi RNAs in the diagnosis, treatment, and prognosis evaluation of the digestive tract cancer. Methods Domestic and international papers focusing on the relationship between mi RNAs and the digestive tract cancer were retrieved and reviewed. Results Mi RNAs participated in cell proliferation, differentiation, and apoptosis through gene regulation. The patients with digestive tract cancer were often accompanied with some abnormal expression of mi RNAs in circulation, that was closely related to the occurrence and development of tumor. These mi RNAs in blood contributed to not only the diagnosis of tumor, but also identification of the primary tumor site, even the clinical and pathological staging. Thus, we could predict the progress, recurrence, and the metastasis of tumor, or perform the evaluation of therapeutic effects. Conclusion Circulating mi RNAs can be used as molecular microsensors for the noninvasive early diagnosis, treatment, and prognosis of the digestive tract cancer.
出处 《中国普外基础与临床杂志》 CAS 2015年第3期365-368,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金青年基金(项目编号:81202580)~~
关键词 循环小分子RNA 消化道肿瘤 肿瘤标志物 Circulating micro RNAs Digestive tract cancer Biomarker of tumor
  • 相关文献

参考文献3

二级参考文献57

  • 1Do-Joong Park,Hyeon-Kook Lee,Hyuk-Joon Lee,Hye-SeungLee,Woo-HoKim,Han-Kwang Yang,Kuhn-UkLee,Kuk-JinChoe.Lymph node metastasis in early gastric cancer with submucosal invasion:Feasibility of minimally invasive surgery[J].World Journal of Gastroenterology,2004,10(24):3549-3552. 被引量:22
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.

共引文献1019

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部